Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Arterial Spin-Labeling Perfusion MRI Stratifies Progression-Free Survival and Correlates with Epidermal Growth Factor Receptor Status in Glioblastoma
Authors
Keywords
-
Journal
AMERICAN JOURNAL OF NEURORADIOLOGY
Volume 36, Issue 4, Pages 672-677
Publisher
American Society of Neuroradiology (ASNR)
Online
2014-12-27
DOI
10.3174/ajnr.a4196
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Is deferred use of bevacizumab for glioblastoma associated with prolonged survival?
- (2014) Q. G. D'Alessandris et al. NEURO-ONCOLOGY
- Dynamic-susceptibility contrast agent MRI measures of relative cerebral blood volume predict response to bevacizumab in recurrent high-grade glioma
- (2014) K. M. Schmainda et al. NEURO-ONCOLOGY
- Correlation of diffusion tensor, dynamic susceptibility contrast MRI and 99mTc-Tetrofosmin brain SPECT with tumour grade and Ki-67 immunohistochemistry in glioma
- (2013) George A. Alexiou et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Grading of Cerebral Glioma with Multiparametric MR Imaging and 18F-FDG-PET: Concordance and Accuracy
- (2013) Jeong Hee Yoon et al. EUROPEAN RADIOLOGY
- Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes
- (2013) Rajiv Mangla et al. JOURNAL OF NEURO-ONCOLOGY
- Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma
- (2013) Peter S. LaViolette et al. NEURO-ONCOLOGY
- Multi-delay multi-parametric arterial spin-labeled perfusion MRI in acute ischemic stroke — Comparison with dynamic susceptibility contrast enhanced perfusion imaging
- (2013) Danny J.J. Wang et al. NeuroImage-Clinical
- Use of magnetic perfusion-weighted imaging to determine epidermal growth factor receptor variant III expression in glioblastoma
- (2012) Elana S. Tykocinski et al. NEURO-ONCOLOGY
- The Value of Arterial Spin-Labeled Perfusion Imaging in Acute Ischemic Stroke
- (2012) Danny J.J. Wang et al. STROKE
- Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma
- (2011) L.S. Hu et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Exciting New Advances in Neuro-Oncology: The Avenue to a Cure for Malignant Glioma
- (2010) E. G. Van Meir et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biopsy Targeting Gliomas
- (2010) Marc-André Weber et al. INVESTIGATIVE RADIOLOGY
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
- (2010) Patrick Y. Wen et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of perfusion MRI-derived parameters in evaluating and predicting response to antiangiogenic therapy in patients with newly diagnosed glioblastoma
- (2010) E. Essock-Burns et al. NEURO-ONCOLOGY
- The EGFRvIII variant in glioblastoma multiforme
- (2009) Hui K. Gan et al. JOURNAL OF CLINICAL NEUROSCIENCE
- RETRACTED ARTICLE: Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging
- (2009) H. R. Arvinda et al. JOURNAL OF NEURO-ONCOLOGY
- Perfusion Imaging of Brain Tumors Using Arterial Spin-Labeling: Correlation with Histopathologic Vascular Density
- (2008) T. Noguchi et al. AMERICAN JOURNAL OF NEURORADIOLOGY
- Development of a Real-time RT-PCR Assay for Detecting EGFRvIII in Glioblastoma Samples
- (2008) K. Yoshimoto et al. CLINICAL CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started